Artificial intelligence in a lung disease clinic
Part of Lungs & breathing clinical trials.
This study uses artificial intelligence to help doctors better understand and care for people with interstitial lung disease. You'll fill out a simple questionnaire to help improve how the clinic works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a patient receiving care at the ILD clinic at Fondazione Policlinico Gemelli in Rome.
- You must be willing and able to sign a consent form.
- You must be able to fill out a questionnaire (you can have help if needed).
- You cannot be someone who sent the email questionnaire to patients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a home breathing device, combined with artificial intelligence, can help monitor your lung condition between clinic visits. If it works, it might catch changes early and help you stay healthier.
This trial tests whether an artificial intelligence (AI) tool can help prevent, diagnose, and triage respiratory diseases. It is open to adults without medical training who can follow a survey.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
This study uses artificial intelligence to analyze CT scans and other health data to better identify people at risk for smoking-related diseases like lung cancer. Researchers hope to improve early detection and prevention.
This study tests how well an AI tool can predict lung cancer risk, based on your health information. It looks at how patients feel about this approach to screening, with the goal of making screening more personal and effective.
Hear when a new Interstitial Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.